Biotia’s clinical study, published in Microbiology Spectrum, validates an NGS and machine learning assay for UTIs, reporting 97.2% sensitivity and 99.6% specificity in direct detection and AMR profiling from urine samples.
n6 has launched the icon16, a 16-well NGS library prep instrument for low-throughput clinical and research labs, featuring per-well real-time amplification control using the company’s AutoNorm technology.
The integrated testing approach combines genomic profiling with immunohistochemistry to support faster treatment decisions for advanced-stage cancer patients.
Weill Cornell Medicine researchers report a whole-genome sequencing algorithm may identify more patients for PARP inhibitor cancer therapies than current commercial tests, according to a study in Communications Medicine.
Read More